Related Experiment Video

Updated: Jun 4, 2025

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection
05:10

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection

Published on: August 20, 2007

6.1K

Engineering immunity with nanoparticles: highlights from recent research on transplant rejection therapy

Marco Galli1, Stefano Cozzi1, Francesca Granucci

  • 1Department of Biotechnology and Biosciences, University of Milano Bicocca, Milan, Italy.

Nanomedicine (London, England)
|December 18, 2024
PubMed
Summary

No abstract available in PubMed .

Keywords:
Immunology/Infectious diseasesadaptive immunitycalcineurin/NFATimmune toleranceinnate immunitynanoparticlestransplant rejection

More Related Videos

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K
Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

898

Related Experiment Videos

Last Updated: Jun 4, 2025

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection
05:10

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection

Published on: August 20, 2007

6.1K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K
Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

898

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

66.9K
Overview
66.9K

Articles linked to this work by shared authors, journal, and citation graph.

Calcineurin/NFAT signaling in the temporal integration of Ca²⁺ stress in neurodegeneration.

Cell death discovery·2026

Dipeptidyl peptidase 3 sets the threshold for immune activation and survival during experimental bacterial infection.

Nature communications·2026

Skin Application of Inflammasome Inhibitor MCC950 Prevents Psoriasis-like Cutaneous Manifestations and Associated Systemic Inflammation.

Inflammation·2026

Treatment of Acute Myeloid Leukemias and Myelodisplastic Syndromes Relapsing After Allogeneic Stem Cell Transplantation: An In-Depth Analysis of the GITMO AML/MDS-Relapse Registry Study.

Clinical lymphoma, myeloma & leukemia·2026

Highly differentiated T cells link systemic and vascular inflammation in a mouse model of recurrent psoriasis.

Frontiers in immunology·2025

Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplant.

Annals of hematology·2025

Cationic lipid-based targeted nanocarriers for respiratory diseases in children: prospects and challenges.

Nanomedicine (London, England)·2026

LPR-1-Mediated targeted intranasal delivery of lentinan-loaded polymeric nanocarriers for GBM therapy via modulation of apoptotic signalling.

Nanomedicine (London, England)·2026

Intradermal immunoengineering with mRNA.

Nanomedicine (London, England)·2026

Considerations for nanoscale drug-delivery systems for the cornea.

Nanomedicine (London, England)·2026

Advances in the development and application of nanofibrous systems for intranasal drug delivery.

Nanomedicine (London, England)·2026

Bacterial extracellular vesicles: mechanisms, engineering strategies, and therapeutic potential for inflammatory bowel disease.

Nanomedicine (London, England)·2026

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

Cancer immunology research·2026

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Practice Patterns in Inflammatory Bowel Disease in Pakistan: A National Survey of Physician Confidence and Therapeutic Strategies.

Inflammatory intestinal diseases·2026

The Role of Chimeric Antigen Receptor Regulatory T Cells in Promoting Immune Tolerance in Solid Organ Transplantation: Mechanisms and Therapeutic Potential.

Saudi medical journal·2026

Chrono-immunotherapy in genitourinary oncology: From emerging evidence to clinical translation (Review).

Oncology letters·2026

Astragaloside IV suppresses triple-negative breast cancer cell migration and invasion by targeting BCAT1-mediated branched-chain amino acid metabolism.

Oncology letters·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us